What is Inception Sciences?
Inception Sciences is dedicated to pioneering transformational biotechnology companies by harnessing groundbreaking scientific advancements. The firm concentrates on developing novel therapeutic solutions for critical unmet medical needs across various disease areas, leveraging its advanced wet-lab capabilities and strategic alliances. Its team comprises seasoned drug developers with a proven history of successfully advancing pharmaceuticals from discovery to market. Inception Sciences aims to exploit innovative technologies to propel progress within the biotechnology landscape.
How much funding has Inception Sciences raised?
Inception Sciences has raised a total of $4.1M across 1 funding round:
Series A
$4.1M
Series A (2015): $4.1M with participation from Versant Ventures, Fonds de solidarit_, and Inserm Transfert Initiative
Key Investors in Inception Sciences
Versant Ventures
Versant Ventures is a venture capital firm specializing in building and funding innovative biotechnology companies globally. With substantial assets under management, they have a strong history of successful IPOs and M&A transactions, leveraging their experienced team and extensive scientific resources.
Fonds de solidarit_
Fonds de Solidarité FTQ is a private equity and venture capital firm based in Canada, focusing on investments in start-ups, early ventures, mergers, and business acquisitions.
Inserm Transfert Initiative
Inserm Transfert Initiative facilitates the translation of medical research from the lab to practical applications, connecting scientific discoveries with companies and investors to develop new health innovations and treatments.
What's next for Inception Sciences?
The recent major strategic investment in Inception Sciences signals a pivotal moment for the company, likely indicating a transition into a scaling phase. This capital infusion is expected to accelerate the development of its pipeline, expand its research and development infrastructure, and potentially forge new strategic partnerships. The company's focus on addressing unmet medical needs positions it for significant growth and impact within the biotechnology industry, with a clear trajectory towards clinical validation and market entry.
See full Inception Sciences company page
